Genky DrugStores Co., Ltd. (JP:9267)
:9267
Want to see JP:9267 full AI Analyst Report?
9267 Stock Chart & Stats
¥4960.00
-¥60.00(-1.91%)
At close: 4:00 PM EST
¥4960.00
-¥60.00(-1.91%)
Day’s Range― - ―
52-Week Range¥3,370.00 - ¥5,460.00
Previous CloseN/A
Volume44.10K
Average Volume (3M)62.69K
Market Cap
¥111.25B
Enterprise Value¥137.55B
Total Cash (Recent Filing)¥6.22B
Total Debt (Recent Filing)¥34.37B
Price to Earnings (P/E)18.9
Beta0.44
Next Earnings
Jul 28, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.25%
Share Statistics
EPS (TTM)232.48
Shares Outstanding31,031,569
10 Day Avg. Volume60,060
30 Day Avg. Volume62,690
Financial Highlights & Ratios
PEG Ratio1.41
Price to Book (P/B)2.17
Price to Sales (P/S)0.58
P/FCF Ratio-46.47
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)260.7
Revenue Forecast (FY)¥222.15B
Bulls Say, Bears Say
Bulls Say
Stable Retail Drugstore ModelGenky's core store-based retail model centers on essential health, pharmacy, and daily-consumption items that drive repeat purchases. This product mix and physical footprint support predictable sales and customer loyalty, making revenue streams resilient to short-term volatility and durable over months.
Consistent Revenue And Healthy MarginsSustained revenue growth with a healthy gross margin indicates effective procurement, pricing and SKU mix management. Stable operating margins and improving net margin support ongoing profitability and provide a structural buffer to absorb cost pressures while funding operations and selective reinvestment over the medium term.
Solid Balance Sheet And Strong ROEA moderate leverage profile and a robust ROE reflect prudent capital structure and efficient use of equity to generate returns. This financial strength enhances flexibility for store investments, supplier negotiation, or opportunistic M&A and lowers refinancing risk across economic cycles.
Bears Say
Negative Free Cash FlowDespite operating cash flow strength, a sharp decline into negative free cash flow signals capex or working-capital stress that reduces internal funding capacity. Persisting FCF deficits could force reliance on external financing, constrain reinvestment or dividend flexibility and weaken long-term financial optionality.
Minimal Dividend YieldA very low dividend yield suggests limited income return to shareholders, which reduces appeal to yield-focused investors and offers little downside price support. If cash generation remains constrained, management may not materially raise payouts, limiting shareholder value capture over the medium term.
Dependence On Physical Foot TrafficRevenue tied heavily to in-store foot traffic and repeat visits exposes the company to secular shifts toward e-commerce and changing shopper habits. Without strong omnichannel execution, market share and sales per store could erode, pressuring margins and growth over the next several quarters.
Genky DrugStores Co., Ltd. News
9267 FAQ
What was Genky DrugStores Co., Ltd.’s price range in the past 12 months?
Genky DrugStores Co., Ltd. lowest stock price was ¥3370.00 and its highest was ¥5460.00 in the past 12 months.
What is Genky DrugStores Co., Ltd.’s market cap?
Genky DrugStores Co., Ltd.’s market cap is ¥111.25B.
When is Genky DrugStores Co., Ltd.’s upcoming earnings report date?
Genky DrugStores Co., Ltd.’s upcoming earnings report date is Jul 28, 2026 which is in 72 days.
How were Genky DrugStores Co., Ltd.’s earnings last quarter?
Genky DrugStores Co., Ltd. released its earnings results on Apr 28, 2026. The company reported ¥52.49 earnings per share for the quarter, beating the consensus estimate of N/A by ¥52.49.
Is Genky DrugStores Co., Ltd. overvalued?
According to Wall Street analysts Genky DrugStores Co., Ltd.’s price is currently Overvalued.
Does Genky DrugStores Co., Ltd. pay dividends?
Genky DrugStores Co., Ltd. pays a Semiannually dividend of ¥6.5 which represents an annual dividend yield of 0.25%. See more information on Genky DrugStores Co., Ltd. dividends here
What is Genky DrugStores Co., Ltd.’s EPS estimate?
Genky DrugStores Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Genky DrugStores Co., Ltd. have?
Genky DrugStores Co., Ltd. has 31,031,569 shares outstanding.
What happened to Genky DrugStores Co., Ltd.’s price movement after its last earnings report?
Genky DrugStores Co., Ltd. reported an EPS of ¥52.49 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 1.135%.
Which hedge fund is a major shareholder of Genky DrugStores Co., Ltd.?
Currently, no hedge funds are holding shares in JP:9267
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Genky DrugStores Co., Ltd.
Genky DrugStores Co., Ltd. operates a chain of drug stores. The company was founded in 1988 and is headquartered in Sakai, Japan.
Technical Analysis
Sundrug Co
―
Sugi Holdings Co
―
TSURUHA Holdings
―
COSMOS Pharmaceutical Corporation
―
KUSURI NO AOKI HOLDINGS CO.,LTD.
―
Options Prices
Currently, No data available
---